Bio-Techne Announces New Customer Experience Centre in Düsseldorf, Germany
Bio-Techne (NASDAQ: TECH) has announced plans to open a new Customer Experience Centre in Düsseldorf, Germany by summer 2026, aimed at serving the EMEA (Europe, Middle East and Africa) region. The facility will feature a state-of-the-art Demonstration Laboratory showcasing the company's complete instrument portfolio.
Key highlights include the newly launched Leo™ System with Simple Western™ Technology for automated western blot assays, and the COMET™ spatial biology platform for automated, high-throughput tissue profiling. The center will complement Bio-Techne's existing UK facility, allowing for expanded customer demonstrations and hands-on experience with their instruments.
The strategic location in Düsseldorf was selected for its vibrant life sciences sector and proximity to the Benelux region, facilitating access to multiple European markets. This expansion will enable Bio-Techne to grow its customer-facing team in EMEA and support long-term regional growth, particularly in the German market.
Bio-Techne (NASDAQ: TECH) ha annunciato piani per aprire un nuovo Centro Esperienza Clienti a Düsseldorf, Germania entro l'estate del 2026, con l'obiettivo di servire la regione EMEA (Europa, Medio Oriente e Africa). La struttura presenterà un laboratorio dimostrativo all'avanguardia che mostrerà l'intero portafoglio di strumenti dell'azienda.
I punti salienti includono il nuovo Leo™ System con tecnologia Simple Western™ per saggi di western blot automatizzati, e la piattaforma di biologia spaziale COMET™ per il profiling tissutale automatizzato e ad alta capacità. Il centro completerà la struttura esistente di Bio-Techne nel Regno Unito, consentendo dimostrazioni più ampie per i clienti e un'esperienza pratica con i loro strumenti.
La posizione strategica a Düsseldorf è stata scelta per il suo vivace settore delle scienze della vita e la vicinanza alla regione Benelux, facilitando l'accesso a diversi mercati europei. Questa espansione permetterà a Bio-Techne di crescere il proprio team a contatto con i clienti in EMEA e supportare la crescita regionale a lungo termine, in particolare nel mercato tedesco.
Bio-Techne (NASDAQ: TECH) ha anunciado planes para abrir un nuevo Centro de Experiencia del Cliente en Düsseldorf, Alemania para el verano de 2026, con el objetivo de atender la región EMEA (Europa, Medio Oriente y África). La instalación contará con un laboratorio de demostración de última generación que mostrará todo el portafolio de instrumentos de la compañía.
Los aspectos más destacados incluyen el recién lanzado Leo™ System con tecnología Simple Western™ para ensayos de western blot automatizados, y la plataforma de biología espacial COMET™ para el perfilado de tejidos automatizado y de alto rendimiento. El centro complementará la instalación existente de Bio-Techne en el Reino Unido, permitiendo demostraciones ampliadas para los clientes y experiencia práctica con sus instrumentos.
La ubicación estratégica en Düsseldorf fue seleccionada por su vibrante sector de ciencias de la vida y su proximidad a la región de Benelux, facilitando el acceso a múltiples mercados europeos. Esta expansión permitirá a Bio-Techne hacer crecer su equipo de atención al cliente en EMEA y apoyar el crecimiento regional a largo plazo, especialmente en el mercado alemán.
Bio-Techne (NASDAQ: TECH)는 2026년 여름까지 독일 뒤셀도르프에 새로운 고객 경험 센터를 열 계획을 발표했습니다. 이 센터는 EMEA(유럽, 중동 및 아프리카) 지역을 대상으로 합니다. 이 시설은 회사의 전체 기기 포트폴리오를 선보이는 최첨단 시연 실험실을 갖출 예정입니다.
주요 하이라이트로는 자동화된 웨스턴 블롯 분석을 위한 Simple Western™ 기술을 갖춘 신제품 Leo™ System과 자동화된 고처리량 조직 프로파일링을 위한 COMET™ 공간 생물학 플랫폼이 있습니다. 이 센터는 Bio-Techne의 기존 영국 시설을 보완하여 고객을 위한 더 많은 시연과 기기 사용 경험을 제공할 것입니다.
뒤셀도르프의 전략적 위치는 활기찬 생명 과학 부문과 벨기에, 네덜란드, 룩셈부르크(Benelux) 지역과의 근접성 덕분에 선택되었습니다. 이는 여러 유럽 시장에 접근할 수 있도록 합니다. 이 확장은 Bio-Techne가 EMEA에서 고객 대응 팀을 확장하고 독일 시장에서의 장기적인 지역 성장 지원을 가능하게 할 것입니다.
Bio-Techne (NASDAQ: TECH) a annoncé son intention d'ouvrir un nouveau Centre d'Expérience Client à Düsseldorf, Allemagne, d'ici l'été 2026, afin de servir la région EMEA (Europe, Moyen-Orient et Afrique). L'établissement comprendra un laboratoire de démonstration à la pointe de la technologie, mettant en avant l'ensemble du portefeuille d'instruments de l'entreprise.
Les points forts incluent le nouveau Leo™ System avec la technologie Simple Western™ pour des essais de western blot automatisés, ainsi que la plateforme de biologie spatiale COMET™ pour le profilage tissulaire automatisé et à haut débit. Le centre complétera l'établissement existant de Bio-Techne au Royaume-Uni, permettant des démonstrations clients élargies et une expérience pratique avec leurs instruments.
La localisation stratégique à Düsseldorf a été choisie en raison de son secteur dynamique des sciences de la vie et de sa proximité avec la région Benelux, facilitant l'accès à plusieurs marchés européens. Cette expansion permettra à Bio-Techne de développer son équipe dédiée aux clients dans la région EMEA et de soutenir la croissance régionale à long terme, en particulier sur le marché allemand.
Bio-Techne (NASDAQ: TECH) hat Pläne angekündigt, bis zum Sommer 2026 ein neues Kundenerlebniszentrum in Düsseldorf, Deutschland, zu eröffnen, das darauf abzielt, die EMEA-Region (Europa, Naher Osten und Afrika) zu bedienen. Die Einrichtung wird ein modernes Demonstrationslabor umfassen, das das gesamte Instrumentenportfolio des Unternehmens präsentiert.
Zu den wichtigsten Highlights gehört das neu eingeführte Leo™ System mit der Simple Western™-Technologie für automatisierte Western-Blot-Assays sowie die COMET™-Plattform für räumliche Biologie zur automatisierten, hochdurchsatzfähigen Gewebeprofilierung. Das Zentrum wird die bestehende Einrichtung von Bio-Techne im Vereinigten Königreich ergänzen und erweiterte Kundendemonstrationen sowie praktische Erfahrungen mit ihren Instrumenten ermöglichen.
Der strategische Standort in Düsseldorf wurde aufgrund seines dynamischen Lebenswissenschaftssektors und der Nähe zur Benelux-Region ausgewählt, was den Zugang zu mehreren europäischen Märkten erleichtert. Diese Expansion wird es Bio-Techne ermöglichen, sein kundenorientiertes Team in der EMEA zu vergrößern und das langfristige regionale Wachstum, insbesondere im deutschen Markt, zu unterstützen.
- Strategic expansion into key European market with new demonstration facility
- Potential for increased market penetration in EMEA region
- Enhanced customer support and demonstration capabilities
- None.
The new Customer Experience Centre is scheduled to open in summer 2026 and will feature a state-of-the-art Demonstration Laboratory hosting Bio-Techne's full instrument portfolio, including:
- The recently launched Leo™ System, powered by Simple Western™ Technology, which offers the throughput and precision of standard ELISAs in a fully automated western blot assay, expanding applications in bioanalytical workflows from discovery through commercialization.
- The best-in-class spatial biology platform, COMET™, which is the only fully-automated, high-throughput, hyperplex platform with superior tissue profiling capabilities.
"Our new Customer Experience Centre will complement our existing Demonstration Laboratory in the
The facility's capacity will enable Bio-Techne to grow its customer-facing team in EMEA and support long-term regional growth, including in the large German market.
Düsseldorf was carefully chosen as the site for this new centre due to its thriving life sciences sector and strategic proximity to the Benelux region, providing seamless access to customers from multiple European markets.
About Bio-Techne
Bio-Techne Corporation (NASDAQ: TECH) is a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities. Bio-Techne products assist scientific investigations into biological processes and the nature and progress of specific diseases. They aid in drug discovery efforts and provide the means for accurate clinical tests and diagnoses. With hundreds of thousands of products in its portfolio, Bio-Techne generated approximately
About Bio-Techne Corporation (NASDAQ: TECH)
Contact: David Clair, Vice President, Investor Relations & Corporate Development
david.clair@bio-techne.com
612-656-4416
View original content to download multimedia:https://www.prnewswire.com/news-releases/bio-techne-announces-new-customer-experience-centre-in-dusseldorf-germany-302409810.html
SOURCE Bio-Techne Corporation
FAQ
When will Bio-Techne (TECH) open its new Customer Experience Centre in Düsseldorf?
What key instruments will Bio-Techne (TECH) showcase at the Düsseldorf facility?
Why did Bio-Techne (TECH) choose Düsseldorf for its new Customer Experience Centre?
How will the new Düsseldorf facility impact Bio-Techne's (TECH) EMEA operations?
